Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET

  • Sameer A. Greenall,

    Current address: CSIRO Division of Materials Science and Engineering, Parkville, Victoria, Australia

    Affiliation Oncogenic Signaling Laboratory, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia

  • Ermanno Gherardi,

    Affiliation Medical Research Council Centre, Cambridge, United Kingdom

  • Zhanqi Liu,

    Affiliation Tumour Targeting Laboratory, Ludwig Institute for Cancer Research, Heidelberg, Victoria, Australia

  • Jacqueline F. Donoghue,

    Affiliation Oncogenic Signaling Laboratory, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia

  • Angela A. Vitali,

    Affiliation Tumour Targeting Laboratory, Ludwig Institute for Cancer Research, Heidelberg, Victoria, Australia

  • Qian Li,

    Affiliation Oncogenic Signaling Laboratory, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia

  • Roger Murphy,

    Affiliation Tumour Targeting Laboratory, Ludwig Institute for Cancer Research, Heidelberg, Victoria, Australia

  • Luisa Iamele,

    Affiliation Medical Research Council Centre, Cambridge, United Kingdom

  • Andrew M. Scott ,

    Contributed equally to this work with: Andrew M. Scott, Terrance G. Johns

    Affiliation Tumour Targeting Laboratory, Ludwig Institute for Cancer Research, Heidelberg, Victoria, Australia

  • Terrance G. Johns

    Contributed equally to this work with: Andrew M. Scott, Terrance G. Johns

    terry.johns@monash.edu

    Affiliation Oncogenic Signaling Laboratory, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.